Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Infection Gastrointestinal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02174276
What this trial is testing

Safety and Efficacy of GS-4774 in Combination With Tenofovir Disoproxil Fumarate (TDF) for the Treatment of Participants With Chronic Hepatitis B (CHB) and Who Are Currently Not on Treatment

Who this might be right for
Chronic Hepatitis B
Gilead Sciences 195
Not applicableStudy completedNCT05406089
What this trial is testing

Effects of Antiviral Therapy on Patients With HBV-related HCC

Who this might be right for
Hepatocellular CarcinomaHepatitis B VirusSurvival
First Affiliated Hospital Xi'an Jiaotong University 494
Large-scale testing (Phase 3)Study completedNCT00036608
What this trial is testing

A Phase III Study of Entecavir vs Lamivudine in Chronic Hepatitis B Subjects With Incomplete Response to Lamivudine

Who this might be right for
Chronic Hepatitis B
Bristol-Myers Squibb
Not applicableStudy completedNCT00700050
What this trial is testing

Modulation by Sex Hormones of Inflammation and Susceptibility to Pseudomonas Aeruginosa in Cystic Fibrosis Airways

Who this might be right for
Cystic Fibrosis
The Hospital for Sick Children 28
Large-scale testing (Phase 3)WithdrawnNCT01517308
What this trial is testing

24 VS 48-WEEK TREATMENT WITH PEG-IFN ALPHA-2A IN PATIENTS WITH GENOTYPE 2/3 CHRONIC HEPATITIS C

Who this might be right for
Chronic Hepatitis C
Federico II University
Large-scale testing (Phase 3)WithdrawnNCT00381017
What this trial is testing

Effects of Low-dose Maintenance Peg Interferon Alfa-2b Therapy Versus Supportive Care in Patients With Cirrhotic Hepatitis C With HIV (Study P04371)

Who this might be right for
Hepatitis CLiver CirrhosisHIV Infections
Merck Sharp & Dohme LLC
Large-scale testing (Phase 3)Study completedNCT01854697
What this trial is testing

Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) in People With Hepatitis C Virus Infection Who Have Not Had Treatment Before

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 311
Testing effectiveness (Phase 2)Study completedNCT01180790
What this trial is testing

Safety, Tolerability, and Antiviral Activity of ACH-0141625 or Placebo in Combination With Peginterferon and Ribavirin in Hepatitis C Virus (HCV) Positive Participants

Who this might be right for
Hepatitis C
Alexion Pharmaceuticals, Inc. 122
Testing effectiveness (Phase 2)Looking for participantsNCT07293910
What this trial is testing

Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection

Who this might be right for
HELICOBACTER PYLORI INFECTIONSHelicobacter InfectionHelicobacter Pylori Gastrointestinal Tract Infection+1 more
Tanta University 132
Post-approval studies (Phase 4)Study completedNCT00353418
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Genotype 1 and Human Immunodeficiency Virus-1 (HIV-1) Co-infection

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 415
Testing effectiveness (Phase 2)Study completedNCT01816490
What this trial is testing

THISTLE - The HIV-HCV Silibinin Trial

Who this might be right for
HIVHepatitis C
University of Zurich 20
Not applicableStudy completedNCT01525810
What this trial is testing

Three-year Follow-up Study of Subjects Who Participated in a Previous Lambda (BMS-914143) Chronic Hepatitis C Clinical Trial

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 218
Not applicableStudy completedNCT04296513
What this trial is testing

Diagnosis of Gastritis, H. Pylori Infection and Atrophic Gastritis in Dyspeptic Patients

Who this might be right for
Gastritis, AtrophicHelicobacter Pylori InfectionIntestinal Metaplasia+1 more
Instituto Ecuatoriano de Enfermedades Digestivas 150
Testing effectiveness (Phase 2)Study completedNCT01026610
What this trial is testing

Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
LG Life Sciences 115
Large-scale testing (Phase 3)Study completedNCT03186313
What this trial is testing

Evaluate the Safety and Efficacy of the Combined Single Dose of Dactavira Plus Or Dactavira in Egyptian Adults With Chronic Genotype 4 HCV Infection

Who this might be right for
Hepatitis C
Egyptian Liver Hospital 72
Not applicableStudy completedNCT00916474
What this trial is testing

Virology Follow up Study in Subjects Previously Treated With Telaprevir

Who this might be right for
Hepatitis C
Vertex Pharmaceuticals Incorporated 408
Not applicableStudy completedNCT02597790
What this trial is testing

A Prospective, Longitudinal Study of Endothelial Function in HIV/HCV Coinfected Subjects

Who this might be right for
HIVHepatitis C
University of California, Los Angeles 87
Not applicableStudy completedNCT06606197
What this trial is testing

Hepatitis C Prevalence in Men Who Have Sex With Men

Who this might be right for
Hepatitis C
Consorci Sanitari de l'Alt Penedès i Garraf 454
Not applicableNot Yet RecruitingNCT07338851
What this trial is testing

The Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L Vaccines

Who this might be right for
PolioMeaslesRubella+2 more
China National Biotec Group Company Limited 600
Testing effectiveness (Phase 2)Study completedNCT01987453
What this trial is testing

Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Participants With Chronic Genotype 1 HCV Who Participated in a Prior Gilead-Sponsored HCV Treatment Study

Who this might be right for
HCV Infection
Gilead Sciences 100
Next Page